Search

Armata Pharmaceuticals announced a $20 Million investment to support advancement of its clinical phage development programs. Armata aims to complete a phage clinical trial (Phase 1b/2a, P. aeruginosa) and initiate three more in 2021-2022.

Holger Buchholz (University of Exeter, UK) and colleagues published a new paper in The ISME Journal showing a high-throughput method for isolating virus-host model systems for fastidious heterotrophic bacteria. Using this method, 117 new ph

Janet Nale (University of Leicester, UK) and colleagues published a new paper in Frontiers in Microbiology on how an optimized phage cocktail they developed can effectively control Salmonella. They administered the three-phage cocktail to G

Jingen Zhu (The Catholic University of America, Washington, DC) and colleagues published a new preprint describing the use of CRISPR-engineered phage T4 as a universal platform to produce vaccines against SARS-CoV-2. They found high levels

Nitasha Menon (Amrita Vishwa Vidyapeetham University, India) and colleagues published a new paper in mSphere on a phage they isolated from sewage that has activity against multidrug resistant clinical isolates of Pseudomonas aeruginosa in S

BCM Tailor labs has posted a video tutorial on how to do a quick phage precipitation. In this video you will learn how to precipitate your phage in 10 to 15 minutes. This is in order to concentrate your phage from a solution. This can be mo

Dr. Pilar García Suárez is editing a Special Issue of the journal Antibiotics called "Benefits of Bacteriophages to Combat Antibiotic-Resistant Bacteria".

RATIO PRESENTS: BACTERIOPHAGES: Join us on 2nd Feb when we will talk about merciless killers – the bacteriophages, small biological machines designed to kill bacteria. This event will give an overview of the main principles of the bacterio

BBC Future has published a great in-depth feature called 'The viruses that prey on human diseases', featuring interviews with directors of the Eliava Institute (Mzia Kutateladze) and Queen Astrid Military Hospital phage therapy unit (Jean-P

Yuping Li and Joseph Bondy-Denomy (University of California San Francisco) published a new review in Cell Host & Microbe discussing how anti-CRISPRs affect the ecology and evolution of bacteria and phage.

Carly Davis (University of Alberta, Canada) and colleagues published a new paper in Microorganisms showing that aztreonam lysine (an antibiotic) increases the activity of phages E79 and phiKZ against Pseudomonas aeruginosa PA01.

Amjad Khan (Western University, Canada) and colleagues published a paper in PLOS Computational Biology showing that evolution along the parasitism-mutualism continuum determines the genetic repertoire of prophages.

In light of the COVID crisis, there seems to be renewed interest in using phages to deliver genetic material in the body. Matthew Tridgett (University of Warwick) and colleagues published a new paper detailing their method for engineering b

PhageAI 0.7.2 has been released! What's new: Life cycle classifier v1.3 to distinguish between virulent and temperate phages (accuracy benchmark); PhageAI as free Python package on GitHub and PyPI; Duplicate samples detection alert in phag

International Bacteriophage Research Consortium on Twitter: "IBRC springs into action with its lecture series - 2021. We have Prof. Paul Turner onboard with us! An expert in steering phages and INSeq mutagenesis, Prof. Turner is an establis

Mayo Clinic is hosting a webinar on machine learning in phage therapy Jan 27 1PM MST. Register here. Featured Speaker: Cedric Lood, Researcher-Arenberg Doctoral Program at KU Leuven University-Belgium. Gina Suh, M.D. and William Faubion, M.

We had a great time kicking off PHAVES for 2021 this week — thanks to everyone who attended! We had an awesome casual chat with phage researchers around the world, heard about what people are working on, what they're proud of from 2020, and

Fantastic turnout for the first Africa Phage Forum webinar this week — thanks to the ~70 attendees who were there, and thanks to Dr. Paul Turner who gave a thought-provoking talk and extensive Q&A! Sign up for future Africa Phage Forum eve

Paris phage biotech company Eligo Bioscience announced a new agreement worth up to $224M with GlaxoSmithKline, which is aimed at advancing Eligobiotics® for acne treatment/prevention. Eligo employs CRISPR-based phage therapeutics for microb

Anushila Chatterjee (University of Colorado School of Medicine) and colleagues published a new paper in PLOS Genetics showing phage infection and sub-lethal antibiotic exposure mediate Enterococcus faecalis type VII secretion system depende